Search results for "Anticoagulation"
Aspirin for COVID-19 inpatients didn't reduce mortality, trial finds
New data from the RECOVERY trial found a slight reduction in clots but an increase in bleeding and no difference in 28-day mortality in patients randomized to daily aspirin during hospitalization compared to those receiving usual care.
https://acphospitalist.acponline.org/weekly/archives/2021/11/24/2.htm
24 Nov 2021
Combating clots in COVID-19
Critical care experts advised on appropriate prophylaxis for ward and ICU patients as part of the CHEST 2021 conference.
https://acphospitalist.acponline.org/archives/2021/11/combating-clots-in-covid-19.htm
15 Nov 2021
Heparin dosing for COVID-19 inpatients, expert perspectives on boosters
Two new trials offered some support for therapeutic anticoagulation in inpatients with elevated d-dimer levels. Antithrombotic therapy didn't prove helpful for outpatients with COVID-19. FDA advisors, an ACP/Annals forum, and recent research addressed vaccine effectiveness and boosters.
https://acphospitalist.acponline.org/weekly/archives/2021/10/20/1.htm
20 Oct 2021
Mixed news on anticoagulation; new data on myocarditis, postexposure prophylaxis
Full-dose anticoagulation appeared to help hospitalized COVID-19 patients who weren't critically ill but not the critically ill, trials showed. Postvaccine myocarditis and pericarditis were investigated by a study, while new data and an FDA authorization supported postexposure prophylaxis for some patients.
https://acphospitalist.acponline.org/weekly/archives/2021/08/11/1.htm
11 Aug 2021
Guidelines updated on use of antithrombotics for VTE
CHEST modified its 2016 recommendations on venous thromboembolism (VTE) management, with changes including the addition of cerebral vein thrombosis as a topic and strengthened support for outpatient VTE treatment.
https://acphospitalist.acponline.org/weekly/archives/2021/08/11/2.htm
11 Aug 2021
Pandemic lessons, VTE prediction, and COVID-19 effects on other inpatients
One hospital reduced unnecessary labs during the pandemic, while another collected nine lessons to improve health care. Other recent studies looked at venous thromboembolism (VTE) in COVID-19 inpatients and mortality rates among patients hospitalized for other conditions during last year's surges.
https://acphospitalist.acponline.org/weekly/archives/2021/07/28/1.htm
28 Jul 2021
COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia
Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
https://acphospitalist.acponline.org/weekly/archives/2021/06/16/1.htm
16 Jun 2021
Review finds 18% mortality in severe DOAC-related bleeding treated with reversal agent
A systematic review looked at 60 studies that evaluated four-factor prothrombin complex concentrates, idarucizumab, or andexanet for the treatment of severe or uncontrolled bleeding in patients on a direct oral anticoagulant (DOAC).
https://acphospitalist.acponline.org/weekly/archives/2021/06/16/4.htm
16 Jun 2021
Three common, commonly missed poisons
Identify carbon monoxide, metformin, and salicylates when they strike.
https://acphospitalist.acponline.org/archives/2021/06/three-common-commonly-missed-poisons.htm
15 Jun 2021
Take cardiac symptoms in women seriously
An expert reviewed conditions with different presentations or higher incidence in women.
https://acphospitalist.acponline.org/archives/2021/06/take-cardiac-symptoms-in-women-seriously.htm
15 Jun 2021